MedicalDevice Licensing.com
Innovaro Pharmalicensing
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Innovaro Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Innovaro Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd
Innovaro Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..7 of 7 - per page
Order by
NGR peptides for targeting therapeutic and diagnostic agents to cancer cells More
A strategy for artificially inducing the internalization of surface receptors, thereby blocking the effects of the ligands associated with that receptor More
A prolidase expression construct and a method of using the construct to isolate stable transfectants with high prolidase expression More
These coding sequences have successfully been delivered to endothelial cells and tumor cells both in vitro and in vivo, and have demonstrated significant anti-tumor activity. More
A novel therapy for the suppression of cancer metastasis onset.Metastasis, the spread of tumor cells from the primary site to distant organ environments, is the leading cause of death from cancer. A key turning point in the course of cancer progression... More
Delivery of contrast material to tumor cells can be compromised by the abundance of perivascular stroma myofibroblasts that hinder transfer of materials from the vessels to the tumor cells. Evoking an alternate competing endocytic pathway using a novel... More
Novel molecules for the treatment of angiogenesis-dependent diseases. Angiogenesis, the formation of new blood vessels, is implicated in the onset of a wide range of diseases such as age-related macular degeneration, corneal neovascularization and... More
Displaying 1..7 of 7 - per page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Biotech 10
Press releases: Innovaro Pharmalicensing current industry press releases.

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us